Locally advanced breast cancer in Latin America

The rehabilitation of breast cancer survivors

Nivolumab in combination with CIMAvax-EGF for lung cancer

Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia

Bispecific CD19/22 CAR therapy in children and young adults with ALL

Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent therapy

Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smouldering multiple myeloma

Indoximod combined with chemotherapy in newly diagnosed AML patients

Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL

CAR-T cell dosing approaches in treating acute lymphoblastic leukaemia

Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation

Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia